Iveda Solutions (IVDA) holders report 585,068 shares; warrants capped at 4.99%

Rhea-AI Filing Summary

Iveda Solutions disclosure of beneficial ownership by Iroquois Capital Management, Richard Abbe and Kimberly Page. The filing reports each Reporting Person as beneficially owning 585,068 shares of Common Stock, reflecting shares issuable upon exercise of warrants that are subject to 4.99% Beneficial Ownership Blockers. The Form 10-K shows 11,139,740 shares outstanding as of March 15, 2026, and the warrants described are exercisable for up to 1,000,000 and 428,572 shares respectively but cannot be exercised beyond the 4.99% limit.

Insights

Corporate Governance Analyst

Filing documents capped warrant exercises to 4.99% ownership per holder.

The statement explains that warrants held by Iroquois Master Fund and ICIG are exercisable for up to 1,000,000 and 428,572 shares, respectively, but contain Beneficial Ownership Blockers that prevent exercise above 4.99% ownership. This filing reports the post-blocker beneficial ownership as 585,068 shares per Reporting Person where applicable.

The ownership counts are tied to the company’s reported share base of 11,139,740 shares outstanding as of March 15, 2026; subsequent filings would be needed for updated share counts or blocker mechanics.

Securities Compliance Specialist

Clear attribution and disclaimers are provided for beneficial ownership.

The filing attributes holdings to Iroquois Capital, Richard Abbe and Kimberly Page and includes disclaimers that each Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest. It also states that certain warrants are not exercisable due to the blocker provisions.

Cash‑flow treatment for warrant exercise and any issuer proceeds are not described in this excerpt; related prospectus or purchase agreements would contain those terms.

Key Figures

Shares outstanding: 11,139,740 shares Reported beneficial ownership (per reporting person): 585,068 shares Warrants exercisable (IMF): 1,000,000 shares +2 more

5 metrics

Shares outstanding 11,139,740 shares as of March 15, 2026

Reported beneficial ownership (per reporting person) 585,068 shares reported on each Reporting Person's cover page

Warrants exercisable (IMF) 1,000,000 shares warrants held directly by IMF (subject to blockers)

Warrants exercisable (ICIG) 428,572 shares warrants held directly by ICIG (subject to blockers)

Beneficial ownership cap 4.99% Beneficial Ownership Blockers limiting warrant exercise

Key Terms

Beneficial Ownership Blockers, Warrants, Beneficially owned

3 terms

Beneficial Ownership Blockers regulatory

"The Warrants contain provisions which precludes the exercise of such Warrants to the extent"

Warrants financial

"warrants held directly by IMF that are exercisable for an aggregate of up to 1,000,000 shares"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

Beneficially owned regulatory

"aggregate number of shares of securities of the Issuer beneficially owned by such Reporting Person"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Iveda Solutions

(Name of Issuer)

Common Stock

(Title of Class of Securities)

46583A303

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 46583A303

1

Names of Reporting Persons

Iroquois Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 585,068.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 585,068.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

585,068.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Includes 585,068 shares of Common Stock issuable upon the exercise of the Warrants (as defined in Item 4). As more fully described in Item 4, the Warrants are subject to 4.99% Beneficial Ownership Blockers, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.

SCHEDULE 13G

CUSIP Number(s): 46583A303

1

Names of Reporting Persons

Richard Abbe

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 428,572.00
6	Shared Voting Power 585,068.00
7	Sole Dispositive Power 428,572.00
8	Shared Dispositive Power 585,068.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

585,068.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

Comment for Type of Reporting Person: Includes 585,068 shares of Common Stock issuable upon the exercise of the Warrants (as defined in Item 4). As more fully described in Item 4, the Warrants are subject to 4.99% Beneficial Ownership Blockers, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.

SCHEDULE 13G

CUSIP Number(s): 46583A303

1

Names of Reporting Persons

Kimberly Page

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 585,068.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 585,068.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

585,068.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.99 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Includes 585,068 shares of Common Stock issuable upon the exercise of the Warrants (as defined in Item 4). As more fully described in Item 4, the Warrants are subject to 4.99% Beneficial Ownership Blockers, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The Warrants are not currently exercisable due to the Beneficial Ownership Blockers. The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Iveda Solutions
(b)	Address of issuer's principal executive offices: 1744 S. Val Vista, Suite 213 Mesa, Arizona 85204
Item 2.
(a)	Name of person filing: This statement is being filed by (i) Iroquois Capital Management LLC, a Delaware limited liability company ("Iroquois"), (ii) Richard Abbe, and (iii) Kimberly Page ("Mr. Abbe" and "Ms. Page," together with Iroquois, the "Reporting Persons"). Mr. Abbe shares authority and responsibility for the investments made on behalf of Iroquois Master Fund Ltd. ("IMF") with Ms. Kimberly Page, each of whom is a director of IMF. As such, Mr. Abbe and Ms. Page may each be deemed to be the beneficial owner of all shares of Common Stock held by IMF. Iroquois Capital is the investment advisor for IMF and Mr. Abbe is the President of Iroquois Capital. Mr. Abbe has the sole authority and responsibility for the investments made on behalf of Iroquois Capital Investment Group LLC ("ICIG"). As such, Mr. Abbe may be deemed to be the beneficial owner of all shares of Common Stock held by Iroquois Master Fund and ICIG. The foregoing should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of shares of Common Stock owned by another Reporting Person. Each of the Reporting Persons disclaim beneficial ownership of these shares, except to the extent of its, his or her pecuniary interest in such shares, if any.
(b)	Address or principal business office or, if none, residence: The principal business address for each of the Reporting Persons is 2 Overhill Road, Scarsdale, NY 10583.
(c)	Citizenship: Iroquois Capital Management LLC is a Delaware limited liability company. Richard Abbe is an individual who is a citizen of the United States of America. Kimberly Page is an individual who is a citizen of the United States of America.
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 46583A303
Item 4.	Ownership
(a)	Amount beneficially owned: Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of shares of securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference. The Reporting Persons' ownership of the Issuer's securities includes: (i) warrants held directly by IMF that are exercisable for an aggregate of up to 1,000,000 shares of Common Stock and warrants held directly by ICIG that are exercisable for an aggregate of up to 428,572 shares of Common Stock (collectively, the "Warrants"), all of which are subject to 4.99% Beneficial Ownership Blockers (as defined below). The Warrants contain provisions which precludes the exercise of such Warrants to the extent that, following exercise, the holder, together with its affiliates and other attribution parties, would own more than 4.99% of the Common Stock outstanding (the "Beneficial Ownership Blockers"). The shares of Common Stock listed as beneficially owned in Rows 5, 6, 7, 8 and 9 of the cover page for each Reporting Person and the percentage set forth in Row 11 of the cover page for each Reporting Person give effect to the Beneficial Ownership Blockers. Consequently, as of the date of the event which requires the filing of this statement, the Reporting Persons were not able to exercise all of the Warrants due to the Beneficial Ownership Blockers.
(b)	Percent of class: Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference. The Company's Annual Report on Form 10-K filed on March 31, 2026, indicates there were 11,139,740 shares of Common Stock outstanding as of March 15, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(ii) Shared power to vote or to direct the vote: The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iii) Sole power to dispose or to direct the disposition of: The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iv) Shared power to dispose or to direct the disposition of: The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Iroquois Capital Management, LLC

Signature:	/s/ Richard Abbe
Name/Title:	Richard Abbe, President
Date:	05/14/2026

Richard Abbe

Signature:	/s/ Richard Abbe
Name/Title:	Richard Abbe
Date:	05/14/2026

Kimberly Page

Signature:	/s/ Kimberly Page
Name/Title:	Kimberly Page
Date:	05/14/2026

FAQ

What stake does Iroquois Capital report in Iveda Solutions (IVDA)?

Iroquois reports beneficially owning 585,068 shares as shown on its cover page. This figure reflects shares issuable upon exercise of warrants, adjusted to honor the 4.99% Beneficial Ownership Blockers described in Item 4.

How many Iveda Solutions shares were outstanding as reported in this filing?

The filing cites the Form 10-K reporting 11,139,740 shares outstanding as of March 15, 2026. That outstanding share count is the anchor used to calculate the 4.99% blocker percentages in the ownership rows.

What are the warrant amounts referenced in the filing?

The filing states warrants exercisable for up to 1,000,000 shares held by IMF and up to 428,572 shares held by ICIG. Exercise of those warrants is subject to the 4.99% Beneficial Ownership Blockers described in Item 4.

Are all reported warrants currently exercisable?

No. The filing explains the warrants are subject to 4.99% Beneficial Ownership Blockers, and as of the event date the Reporting Persons were not able to exercise all of the warrants because exercise would exceed the blocker limits.

How do Richard Abbe and Kimberly Page appear in the filing?

Both individuals are listed as Reporting Persons; Mr. Abbe is President of Iroquois Capital and shares authority over IMF with Ms. Page. Each disclaims beneficial ownership except to the extent of any pecuniary interest, per the filing's disclosure.